pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
368
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
NT-101
Wet (Neovascular / Exudative) Macular Degeneration
NexThera Co Ltd
0
catalysts
Phase 1
NVK-029
Presbyopia
Vyluma Inc
0
catalysts
Phase 1
NVK-031
Unspecified Ophthalmological Disorders
Vyluma Inc
0
catalysts
Preclinical
NVX-101
rifampicin
← prev
page 7 of 13
next →
131
Pain
89
Neurology
1
Age Related Macular Degeneration
NeoVascularX Inc
0
catalysts
Preclinical
NouvSight-001
Diabetic Retinopathy
iRegene Therapeutics Co Ltd
0
catalysts
Phase 1
OCU-200
Diabetic Macular Edema
$OCGN
Ocugen, Inc.
0
catalysts
Phase 2
OCU-410
Geographic Atrophy
$OCGN
Ocugen, Inc.
0
catalysts
Phase 3
OCU-410ST
Juvenile Macular Degeneration (Stargardt Disease)
$OCGN
Ocugen, Inc.
0
catalysts
Phase 1
OLX-301A
Dry (Atrophic) Macular Degeneration
Laboratoires Thea SA
0
catalysts
Phase 2
OPCT-001
Retinal Degeneration
BlueRock Therapeutics LP
0
catalysts
Phase 2
OPGx-BEST1
Macular Degeneration
$IRD
Opus Genetics, Inc.
0
catalysts
Preclinical
OPGx-CNGB1
Retinitis Pigmentosa (Retinitis)
$IRD
Opus Genetics, Inc.
0
catalysts
Phase 3
OPGx-LCA5
Leber Congenital Amaurosis (LCA)
$IRD
Opus Genetics, Inc.
0
catalysts
Preclinical
OPGx-RDH12
Leber Congenital Amaurosis (LCA)
$IRD
Opus Genetics, Inc.
0
catalysts
Preclinical
OPGx-RHO
Retinitis Pigmentosa (Retinitis)
$IRD
Opus Genetics, Inc.
0
catalysts
Preclinical
OT-004
Leber Congenital Amaurosis (LCA)
Odylia Therapeutics Inc
0
catalysts
Phase 2
OpRegen
Geographic Atrophy
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 2
Optiquel
Non-infectious Uveitis
Enzo Biochem Inc
0
catalysts
Phase 2
PER-001
Diabetic Retinopathy
Perfuse Therapeutics Inc
0
catalysts
Phase 3
PL-9643
Keratoconjunctivitis Sicca (Dry Eye)
$PTNT
PALATIN TECHNOLOGIES INC
0
catalysts
Preclinical
PV-305
Keratitis
VisiRose Inc
0
catalysts
Preclinical
Peroxidases
Dry (Atrophic) Macular Degeneration
Ichor Life Sciences Inc
0
catalysts
Phase 3
Pollinex Quattro Grass
Pollinex
Allergic Rhino-Conjunctivitis
Allergy Therapeutics Plc
0
catalysts
Preclinical
Protearin
Keratoconjunctivitis Sicca (Dry Eye)
Proteris Biotech Inc
0
catalysts
Preclinical
RBIO-101
Reflection Biotechnologies Ltd
0
catalysts
Phase 1
RCI-001
Keratoconjunctivitis Sicca (Dry Eye)
Rudacure Co Ltd
0
catalysts
Preclinical
REV-0100
Juvenile Macular Degeneration (Stargardt Disease)
ReVision Therapeutics Inc
0
catalysts
Phase 2
RG-6351
Diabetic Macular Edema
Genentech Inc
0
catalysts
Preclinical
RO-104
Wet (Neovascular / Exudative) Macular Degeneration
RevOpsis Therapeutics Inc
0
catalysts
Phase 2
RPESCRPE-4W
Dry (Atrophic) Macular Degeneration
Luxa Biotechnology LLC
0
catalysts
